Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Janux Therapeutics Inc
(NQ:
JANX
)
45.92
+1.72 (+3.89%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Janux Therapeutics Inc
< Previous
1
2
3
4
5
Next >
After Soaring 222% in 1 Day, Is Janux Therapeutics Stock a Buy?
March 02, 2024
The biotech tantalized investors with a very promising data update.
Via
The Motley Fool
Janux Therapeutics Announces Pricing of $296.5 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants
February 29, 2024
From
Janux Therapeutics
Via
Business Wire
TG Therapeutics Soars On In-Line Report; Is The Biotech Rally Buoying Shares?
February 28, 2024
The company reported in-line sales for the fourth quarter, but shares soared by double digits.
Via
Investor's Business Daily
Janux Therapeutics Announces Proposed Public Offering of Common Stock
February 27, 2024
From
Janux Therapeutics
Via
Business Wire
Why Is Infobird (IFBD) Stock Up Today?
February 27, 2024
Infobird stock is up on Tuesday after the SaaS company announced a delay to a planned reverse stock split for shares of IFBD.
Via
InvestorPlace
Stocks Mixed As Consumer Confidence Falls
February 27, 2024
Stocks are mixed midday, after the most recent batch of economic data.
Via
Talk Markets
Dow Dips Over 100 Points; J.M. Smucker Posts Upbeat Earnings
February 27, 2024
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index falling more than 100 points on Tuesday. The Dow traded down 0.35% to 38,932.26 while the NASDAQ rose 0.28% to 16,021.41....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
S&P 500, Nasdaq 100 Dip, Small Caps Surge; Bitcoin Tops $57,000, 2 Biotech Stocks Skyrocket: What's Driving Markets Tuesday?
February 27, 2024
On Tuesday, large-cap indices experienced a downturn, while small caps surged, reflecting investor attention on stock valuations.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Cancer-Focused Janux Therapeutics Stock Remains Undervalued Despite Price Surge After Study Data: Analyst
February 27, 2024
JANX Therapeutics' updates in cancer treatment: JANX007 shows promising PSA declines in prostate cancer trials, while JANX008 exhibits encouraging clinical activity in solid tumors.
Via
Benzinga
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 27, 2024
Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 27, 2024
Via
Benzinga
Crude Oil Gains 1%; Macy's Plans To Close 150 Stores
February 27, 2024
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 150 points on Tuesday. The Dow traded down 0.39% to 38,915.65 while the NASDAQ rose 0.15% to 15,999.50. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Norwegian Cruise Line Posts Strong Sales, Joins Hims & Hers Health, Sterling Infrastructure And Other Big Stocks Moving Higher On Tuesday
February 27, 2024
U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Janux Therapeutics Nearly Triples As Prostate Cancer Drug Shows 'Significant Opportunity'
February 27, 2024
The company is working on a treatment for metastatic castration-resistant prostate cancer.
Via
Investor's Business Daily
Nasdaq Rises 50 Points; Lowe's Earnings Top Views
February 27, 2024
U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 50 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.07% to 39,043.13 while the NASDAQ rose...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Aaron’s (AAN) Stock Down 22% Today?
February 27, 2024
Aaron’s stock is taking a beating on Tuesday as AAN investors react to the company's lackluster earnings report for Q4 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 27, 2024
Via
Benzinga
Why TransMedics Group Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket
February 27, 2024
Shares of TransMedics Group, Inc. (NASDAQ: TMDX) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong guidance.
Via
Benzinga
Why Is Janux Therapeutics (JANX) Stock Up 108% Today?
February 27, 2024
Janux Therapeutics stock is rocketing higher on Tuesday after the company provided JANX shareholders with clinical trial updates.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
February 27, 2024
It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news affecting shares on Tuesday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
February 26, 2024
Via
Benzinga
Janux Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for PSMAxCD3-TRACTr JANX007 in mCRPC and EGFRxCD3-TRACTr JANX008 in Solid Tumors
February 26, 2024
From
Janux Therapeutics
Via
Business Wire
Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
February 21, 2024
Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 21, 2024
Via
Benzinga
Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday
February 21, 2024
U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Janux Therapeutics to Host Virtual Event Discussing Updated Clinical Data for PSMA-TRACTr JANX007 and EGFR-TRACTr JANX008
February 20, 2024
From
Janux Therapeutics
Via
Business Wire
Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
February 12, 2024
Shares of Big Lots, Inc. (NYSE: BIG) fell sharply during Monday’s session after the company reported preliminary fourth-quarter results. Also, Loop Capital downgraded the stock from Hold to Sell and...
Via
Benzinga
Janux Therapeutics Promotes Co-Founder Tommy DiRaimondo, Ph.D. to Chief Scientific Officer
January 08, 2024
From
Janux Therapeutics
Via
Business Wire
Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 14, 2023
Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results.
Via
Benzinga
Azenta Reports Upbeat Earnings, Joins Talis Biomedical, Sally Beauty And Other Big Stocks Moving Higher On Tuesday
November 14, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 500 points on Tuesday. Shares of Azenta, Inc. (NASDAQ: AZTA) rose on Tuesday after the company reported better-than-expected fourth-quarter...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.